Reports Q1 revenue $462.33M, consensus $466.93M. “I am very pleased with our strong start to the year, demonstrating our ability to meaningfully grow membership and expand profitability,” said Clover Health (CLOV) CEO Andrew Toy. “Our differentiated model is designed to drive scalable growth and proactively manage our medical costs amidst regulatory changes, outperforming others in the industry, with Clover Assistant. Our recently published clinical whitepaper on Congestive Heart Failure shows that a relationship with a Clover Assistant provider was associated with lower average number of all-cause hospitalizations and 30-day readmissions.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
- Clover Health options imply 11.0% move in share price post-earnings
- CLOV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Clover Health Announces Board Leadership Change
- Clover Health appoints Shelly Gupta as Chief Medical Officer
- Insider Moves: Clean Energy, Warner Bros, Clover Health, Corning, TJX